Baudax Bio Inc (BXRXQ)
OTCMKTS: BXRXQ · Delayed Price · USD
+0.0020 (25.00%)
May 24, 2024, 4:00 PM EDT - Market closed

Baudax Bio Market Cap

Baudax Bio has a market cap or net worth of $79.94 thousand as of May 24, 2024. Its market cap has decreased by -97.72% in one year.

Market Cap
Enterprise Value
1-Year Change
Stock Price

Market Cap Chart

Since November 14, 2019, Baudax Bio's market cap has decreased from $66.10M to $79.94K, a decrease of -99.88%. That is a compound annual growth rate of -81.31%.


DateMarket Cap% Change
Nov 15, 20231.30M-
Nov 14, 20231.30M8.33%
Nov 13, 20231.20M-
Nov 10, 20231.20M-7.69%
Nov 9, 20231.30M-13.33%
Nov 8, 20231.50M-6.25%
Nov 7, 20231.60M-
Nov 6, 20231.60M6.67%
Nov 3, 20231.50M7.14%
Nov 2, 20231.40M7.69%
Nov 1, 20231.30M-
Oct 31, 20231.30M-
Oct 30, 20231.30M18.18%
Oct 27, 20231.10M-8.33%
Oct 26, 20231.20M-7.69%
Oct 25, 20231.30M-7.14%
Oct 24, 20231.40M-
Oct 23, 20231.40M-6.67%
Oct 20, 20231.50M-
Oct 19, 20231.50M-6.25%
Oct 18, 20231.60M14.29%
Oct 17, 20231.40M-12.50%
Oct 16, 20231.60M-11.11%
Oct 13, 20231.80M-14.29%
Oct 12, 20232.10M-4.55%
View and export this data all the way back to 2019. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly 767.39B
Novo Nordisk 602.74B
UnitedHealth Group 467.71B
Johnson & Johnson 353.71B
Merck & Co. 327.97B
AbbVie 277.35B
AstraZeneca 243.51B
Thermo Fisher 222.94B
Market Cap Rankings